AU6496599A - Regulation of her2/neu oncogene expression by synthetic polyamides - Google Patents

Regulation of her2/neu oncogene expression by synthetic polyamides

Info

Publication number
AU6496599A
AU6496599A AU64965/99A AU6496599A AU6496599A AU 6496599 A AU6496599 A AU 6496599A AU 64965/99 A AU64965/99 A AU 64965/99A AU 6496599 A AU6496599 A AU 6496599A AU 6496599 A AU6496599 A AU 6496599A
Authority
AU
Australia
Prior art keywords
her2
regulation
neu oncogene
synthetic polyamides
oncogene expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64965/99A
Inventor
Peter B. Dervan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
California Institute of Technology CalTech
Original Assignee
California Institute of Technology CalTech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Institute of Technology CalTech filed Critical California Institute of Technology CalTech
Publication of AU6496599A publication Critical patent/AU6496599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41781,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU64965/99A 1998-09-11 1999-09-10 Regulation of her2/neu oncogene expression by synthetic polyamides Abandoned AU6496599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9990698P 1998-09-11 1998-09-11
US60099906 1998-09-11
PCT/US1999/020971 WO2000015242A1 (en) 1998-09-11 1999-09-10 REGULATION OF HER2/neu ONCOGENE EXPRESSION BY SYNTHETIC POLYAMIDES

Publications (1)

Publication Number Publication Date
AU6496599A true AU6496599A (en) 2000-04-03

Family

ID=22277188

Family Applications (2)

Application Number Title Priority Date Filing Date
AU60341/99A Ceased AU768405B2 (en) 1998-09-11 1999-09-10 Regulation of HER2/neu oncongene expression by synthetic polyamides
AU64965/99A Abandoned AU6496599A (en) 1998-09-11 1999-09-10 Regulation of her2/neu oncogene expression by synthetic polyamides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU60341/99A Ceased AU768405B2 (en) 1998-09-11 1999-09-10 Regulation of HER2/neu oncongene expression by synthetic polyamides

Country Status (5)

Country Link
EP (2) EP1162961A2 (en)
JP (2) JP2002524501A (en)
AU (2) AU768405B2 (en)
CA (2) CA2344654A1 (en)
WO (2) WO2000015209A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002010368A1 (en) * 2000-07-21 2002-02-07 Chiba Prefecture Tumor-specific promoters
US7122626B2 (en) 2001-04-26 2006-10-17 Genesoft Pharmceuticals, Inc. Halogen-substitued thienyl compounds
AU2002312371A1 (en) 2001-06-13 2002-12-23 Roland W. Burli Aryl-benzimidazole compounds having antiinfective activity
WO2002101007A2 (en) 2001-06-13 2002-12-19 Genesoft Pharmaceuticals, Inc Antipathogenic benzamide compounds
US6825228B2 (en) 2001-06-13 2004-11-30 Genesoft Pharmaceuticals, Inc. Benzothiophene compounds having antiinfective activity
US6777425B2 (en) 2001-06-13 2004-08-17 Genesoft Pharmaceuticals, Inc. Isoquinoline compounds having antiinfective activity
US7498349B2 (en) 2002-08-02 2009-03-03 Genesoft Pharmaceuticals, Inc. Biaryl compounds having anti-infective activity
AU2003285958A1 (en) 2002-10-25 2004-05-25 Genesoft Pharmaceuticals, Inc. Anti-infective biaryl compounds
CA2508769A1 (en) 2002-12-10 2004-06-24 Oscient Pharmaceuticals Corporation Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif
JP3792655B2 (en) 2003-01-20 2006-07-05 日本電気株式会社 Novel oncogene, recombinant protein derived from the oncogene, and uses thereof
JP2006022063A (en) * 2004-07-09 2006-01-26 Univ Nihon Lox-1 gene expression inhibitor
EP3503898A1 (en) * 2016-08-29 2019-07-03 California Institute of Technology Compositions and methods for treatment of prostate cancer
US10723716B2 (en) 2016-12-21 2020-07-28 New York University Alpha-helix mimetics as modulators of Abeta self-assembly

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660255B1 (en) * 1996-08-01 2003-12-09 California Institute Of Technology Inhibition of gene transcription by polyamide DNA-binding ligands

Also Published As

Publication number Publication date
EP1162961A2 (en) 2001-12-19
WO2000015209A2 (en) 2000-03-23
WO2000015209A3 (en) 2000-05-25
WO2000015242A1 (en) 2000-03-23
JP2002524525A (en) 2002-08-06
CA2344654A1 (en) 2000-03-23
EP1112080A1 (en) 2001-07-04
CA2343289A1 (en) 2000-03-23
EP1112080A4 (en) 2002-10-24
JP2002524501A (en) 2002-08-06
AU768405B2 (en) 2003-12-11
AU6034199A (en) 2000-04-03

Similar Documents

Publication Publication Date Title
AU5441096A (en) Analogs of growth hormone-releasing factor
IL123581A0 (en) Pyrimidine derivatives as 5HT2c- receptor antagonists
PL321590A1 (en) Compounds capable to cause liberation of the growth hormone
AU4098096A (en) 2,8-disubstituted quinazolinones
HUP9800028A3 (en) Multiple-tumor aberrant growth genes
ZA98643B (en) Method for inhibiting the growth of cancers
AU6496599A (en) Regulation of her2/neu oncogene expression by synthetic polyamides
ZA964377B (en) A pharmaceutical compositions for inhibiting the growth of cancers.
AU6683396A (en) Use of fluconazole for inhibiting the growth of cancers
IL154111A0 (en) Synthesis of intermediates for the preparation of growth hormone secretagogues
HK1015366A1 (en) Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands
AU6683496A (en) Use of griseofulvin for inhibiting the growth of cancers
AU8282998A (en) Method for producing new hair growth
AU5910899A (en) Inhibition of oncogene transcription by synthetic polyamides
PL310486A1 (en) Novel compounds, derivatives of genistein
AU4775696A (en) Synthetic triple helix-forming compounds
AU4633397A (en) Synthesis of phosphorus compounds
AU2268097A (en) Improved package including holder attachment for tubular applicators
AU4453396A (en) Growth factor analogs
AU7752698A (en) Method for the synthesis of anti-microbial hydroxybenzoats
AU3760595A (en) Methods for regulation of insulin-like growth factor i receptor
EP1304041B8 (en) Feed composition for poultry
EP0781750A3 (en) Asymmetric synthesis of alpha-cycloalkylalkyl substituted methanamines
AU4904800A (en) Identification of compounds for modulating dimeric receptors
PL324400A1 (en) Derivatives of 1,3-oxazin-4-one as herbicides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase